"We hope everyone is enjoying their time in Dragon Age: The Veilguard," BioWare posted on X. "It’s only a few days until N7 ...

Hanmi Pharm. Co., Ltd. has announced promising research results for its novel obesity treatment, HM17321. This groundbreaking drug not only augments fat loss but also significantly increases lean ...

Mass Effect 5 might be in the news and the minds of BioWare fans lately thanks to Dragon Age’s resurgence – but don't get your hopes up this N7 Day ...

Developer BioWare has bad news for Mass Effect fans that want to learn more about the next game in the series.

BioWare has made it clear that it won't have any major Mass Effect announcements to share for this year's N7 Day.

Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8) at three months on setmelanotide ...

Gandja Monteiro, who directed the two-episode finale of Agatha All Along, has taken to social media to share some revealing new behind-the-scenes ...

Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein ...

CRB-913 demonstrated a wide dose response weight loss curve in DIO mice ranging from 5 mg/kg/day to 80 mg/kg/day with no plateauing effect and reaching a weight loss of 31% by day 19. Extending the ...

The Last Attack, the upcoming compilation film of The Final Chapters of the anime, will release in theaters with a new ...

Mass Effect 5's director confirms to fans that one of Dragon Age: The Veilguard's notable features won't be present in the upcoming BioWare game.

Mass Effect: The Board Game - Priority: Hagalaz does a good job adapting the personalities and gameplay of Bioware’s ...